Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project.

Enric SánchezÀngels BetriuCarolina López-CanoMarta HernándezElvira FernándezFrancisco PurroyMarcelino Bermúdez-LópezCristina Farràs-SallésSilvia BarrilReinald PamplonaFerran RiusCristina HernándezRafael SimóAlbert Lecubenull null

Published in: Cardiovascular diabetology (2019)

The prediabetes stage is accompanied by an increased subclinical atheromatous disease only in the presence of other cardiovascular risk factors. Prediabetes modulates the atherogenic effect of cardiovascular risk factors in terms of distribution and total plaque area in a sex-dependent manner. Trial registration NCT03228459 (clinicaltrials.gov).

Keyphrases

cardiovascular risk factors
cardiovascular disease
metabolic syndrome
clinical trial
coronary artery disease
quality improvement
study protocol
phase iii
type diabetes
low density lipoprotein